Risks for infection in patients with myelodysplasia and acute leukemia
Authors:
- Livio PaganoLivio Pagano
- Morena CairaMCMorena Caira
- 1 December 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 25 (6) , 612-618
Abstract
The aim of the present review is to analyze the main parameters that may influence the onset of bacterial, fungal and viral infections in patients with myelodysplastic syndromes, acute myeloid leukemia and acute lymphoid leukemia. The identification of factors influencing the onset of infections in high-risk patients is becoming one of the most important strategies to identify those patients who would really benefit from prophylactic and timely treatment. During the past few years several studies have been conducted to evaluate the impact of risk factors that may influence both the onset and the outcome of infections. The role of some of them is well defined (i.e. neutropenia, central venous catheters), whereas other factors are now emerging as new possible causative factors (i.e. iron overload, hospitalization). Many factors have to be considered when evaluating the infectious risk in hematological patients. In current clinical practice the good knowledge of these factors may favor a better management of infectious risk, with a reduction of mortality rate.Keywords
This publication has 57 references indexed in Scilit:
- A prospective survey of febrile events in hematological malignanciesAnnals of Hematology, 2011
- Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart RegistryArchives of internal medicine (1960), 2011
- Azacitidine for the treatment of lower risk myelodysplastic syndromesCancer, 2010
- Infections in acute myeloid leukemia: an analysis of 382 febrile episodesMedical Oncology, 2009
- Etiology and Clinical Course of Febrile Neutropenia in Children With CancerJournal of Pediatric Hematology/Oncology, 2009
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyThe Lancet Oncology, 2009
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance RegistryClinical Infectious Diseases, 2009
- A Prospective Study on the Epidemiology of Febrile Episodes during Chemotherapy-Induced Neutropenia in Children with Cancer or after Hemopoietic Stem Cell TransplantationClinical Infectious Diseases, 2007
- Risk of bacteraemia and mortality in patients with haematological malignanciesClinical Microbiology and Infection, 2006
- Gram-positive bacteraemia in granulocytopenic cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1990